
On path to likely confirmation as NIH director, Bhattacharya toes the party line
The most telling signal from Jay Bhattacharya’s confirmation hearing as nominee to direct the National Institutes of Health on Wednesday lay in what he would
The most telling signal from Jay Bhattacharya’s confirmation hearing as nominee to direct the National Institutes of Health on Wednesday lay in what he would
A federal judge on Wednesday issued a nationwide preliminary injunction blocking the Trump administration from slashing National Institutes of Health payments for research overhead, a
NEW YORK — The nation’s top public health agency is inviting about 180 employees back to work, about two weeks after laying them off. Emails
Against a backdrop of historical neglect and a future of political uncertainty, Science Advances devoted a special issue to new research and perspectives on women’s
Dive Brief: Philips stopped selling an implant used to repair damaged arteries after reports of 20 injuries and some devices needing to be removed. The
Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies in 2025. Image credit: Shutterstock/ T. Schneider. Sandoz reported
A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
Jay Bhattacharya, President Trump’s nominee to lead the National Institutes of Health, stated during his confirmation hearing Wednesday that he’s “convinced” by the data showing
Patients with disabilities are less likely to feel health care workers treat them respectfully, according to new research from the Perelman School of Medicine at
Researchers at the Herbert Wertheim School of Public Health and Human Longevity Science and Moores Cancer Center at University of California San Diego have found